Advances in study on association between pancreatic carcinoma and hepatitis B virus

doi:10.16139/j.1007-9610.2020.02.018

Abstract

CLC Number:

R735.9

SUN Wentao, DENG Xiaxing. Advances in study on association between pancreatic carcinoma and hepatitis B virus[J]. Journal of Surgery Concepts & Practice, 2020, 25(02): 171-173.

References 29

[30]	Wei XL, Luo HY, Li CF, et al. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers[J]. Int J Cancer, 2017, 141(1):152-159. doi: 10.1002/ijc.30719 URL
[31]	Wei XL, Qiu MZ, Chen WW, et al. The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer[J]. J Transl Med, 2013, 11:249. doi: 10.1186/1479-5876-11-249 URL
[32]	Dumitrascu T, Pineau P, Dima S, et al. Impact of hepatitis B virus on clinicopathological features and outcomes after resection for pancreatic adenocarcinoma[J]. Anticancer Res, 2015, 35(9):5123-5128. pmid: 26254417
[33]	Zhou X, Wang X, Duan J, et al. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas[J]. Pathol Res Pract, 2019, 215(2):343-346. doi: 10.1016/j.prp.2018.12.016 URL
[34]	Oksüzoğlu B, Kiliçkap S, Yalcin S. Reactivation of he- patitis B virus infection in pancreatic cancer: a case report[J]. Jpn J Clin Oncol, 2002, 32(12):543-545. pmid: 12578904
[35]	孙德聪, 陈丽, 吴志勇, 等. 化疗相关乙肝病毒再激活的诊治现状[J]. 中国临床药理学与治疗学, 2014, 19(5):584-590.
[1]	Hassan MM, Li D, El-Deeb AS, et al. Association between hepatitis B virus and pancreatic cancer[J]. J Clin Oncol, 2008, 26(28):4557-4562. doi: 10.1200/JCO.2008.17.3526 pmid: 18824707
[2]	Wang DS, Chen DL, Ren C, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer[J]. Int J Cancer, 2012, 131(2):461-468. doi: 10.1002/ijc.26376 URL
[3]	Ben Q, Li Z, Liu C, et al. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China[J]. Pancreas, 2012, 41(3):435-440. doi: 10.1097/MPA.0b013e31822ca176 URL
[4]	Desai R, Patel U, Sharma S, et al. Association between hepatitis B infection and pancreatic cancer: a population-based analysis in the United States[J]. Pancreas, 2018, 47(7):849-855. doi: 10.1097/MPA.0000000000001095 URL
[5]	Zhu F, Li HR, Du GN, et al. Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China[J]. Asian Pac J Cancer Prev, 2011, 12(6):1405-1408.
[6]	Chang MC, Chen CH, Liang JD, et al. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma[J]. World J Gastroenterol, 2014, 20(17):5060-5065. doi: 10.3748/wjg.v20.i17.5060 URL
[7]	Iloeje UH, Yang HI, Jen CL, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study[J]. Liver Int, 2010, 30(3):423-429. doi: 10.1111/j.1478-3231.2009.02147.x URL
[8]	Tang J, Sharma R, Lamerato L, et al. Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma[J]. J Clin Gastroenterol, 2014, 48(8):729-733. doi: 10.1097/MCG.0000000000000111 URL
[9]	Krull AS, Inoue M, Sawada N, et al. Hepatitis B and C virus infection and risk of pancreatic cancer: a population-based cohort study (JPHC Study CohortⅡ)[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(3):555-557. doi: 10.1158/1055-9965.EPI-15-1115 URL
[10]	Huang J, Magnusson M, Törner A, et al. Risk of pancrea- tic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden[J]. Br J Cancer, 2013, 109(11):2917-2923. doi: 10.1038/bjc.2013.689 URL
[11]	Andersen ES, Omland LH, Jepsen P, et al. Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus[J]. J Viral Hepat, 2015, 22(10):828-834. doi: 10.1111/jvh.12391 URL
[12]	Xing S, Li ZW, Tian YF, et al. Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(6):575-583. doi: 10.1016/S1499-3872(13)60091-0 URL
[13]	Luo G, Hao NB, Hu CJ, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis[J]. Cancer Causes Control, 2013, 24(3):529-537. doi: 10.1007/s10552-012-0144-2 URL
[14]	Fiorino S, Chili E, Bacchi-Reggiani L, et al. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis[J]. Pancreatology, 2013, 13(2):147-160. doi: 10.1016/j.pan.2013.01.005 pmid: 23561973
[15]	Wang Y, Yang S, Song F, et al. Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis[J]. Eur J Cancer Prev, 2013, 22(4):328-334. doi: 10.1097/CEJ.0b013e32835b6a21 URL
[16]	Xu JH, Fu JJ, Wang XL, et al. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies[J]. World J Gastroenterol, 2013, 19(26):4234-4241. doi: 10.3748/wjg.v19.i26.4234 URL
[17]	Dejean A, Lugassy C, Zafrani S, et al. Detection of he- patitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus[J]. J Gen Virol, 1984, 65(Pt 3):651-655. doi: 10.1099/0022-1317-65-3-651 URL
[18]	Hoefs JC, Renner IG, Askhcavai M, et al. Hepatitis B surface antigen in pancreatic and biliary secretions[J]. Gastroenterology, 1980, 79(2):191-194. pmid: 7399225
[19]	Jin Y, Gao H, Chen H, et al. Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues[J]. Cancer Lett, 2013, 335(2):447-454. doi: 10.1016/j.canlet.2013.03.001 URL
[20]	Hohenberger P. The pancreas as target organ for hepatitis B virus--immunohistological detection of HBsAg in pancreatic carcinoma and chronic pancreatitis[J]. Leber Magen Darm, 1985, 15(2):58-63. pmid: 3887078
[21]	Fiorino S, Visani M, Acquaviva G, et al. Search for HBV and HCV genome in cancer cells of pancreatic tumors[J]. Pancreas, 2016, 45(1):e12-e14.
[22]	Pang Y, Kartsonaki C, Guo Y, et al. Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies[J]. Int J Cancer, 2017, 140(8):1781-1788. doi: 10.1002/ijc.30599 URL
[23]	Kirkegård J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2017, 112(9):1366-1372. doi: 10.1038/ajg.2017.218 pmid: 28762376
[24]	Brooks-Worrell B, Palmer JP. Immunology in the clinic review series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation[J]. Clin Exp Immunol, 2012, 167(1):40-46. doi: 10.1111/j.1365-2249.2011.04501.x pmid: 22132883
[25]	Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma[J]. J Hepatol, 2016, 64(1 Suppl):S84-S101. doi: 10.1016/j.jhep.2016.02.021 URL
[26]	Chen Y, Bai X, Zhang Q, et al. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway[J]. Cancer Lett, 2016, 380(1):98-105. doi: 10.1016/j.canlet.2016.06.011 URL
[27]	Fiorino S, Bacchi-Reggiani L, Pontoriero L, et al. Tensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection[J]. JOP, 2014, 15(2):151-164.
[28]	Zou J, Chen J, Xie X, et al. Hepatitis B virus infection is a prognostic biomarker for better survival in operable esophageal cancer: analysis of 2004 patients from an endemic area in China[J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(6):1028-1035. doi: 10.1158/1055-9965.EPI-18-1095 URL
[29]	Tanase AM, Dumitrascu T, Dima S, et al. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(2):162-172. doi: 10.1016/S1499-3872(14)60026-6 URL

Advances in study on association between pancreatic carcinoma and hepatitis B virus

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 29

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHANG Hongzhan, ZHANG Kai. Current status and prospect of endoscopic photodynamic therapy for unresectable extrahepatic cholangiocarcinoma and ampullary carcinoma [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 316-320.
[2]	GAO Pan, CAI Yunqiang, PENG Bing. Function-preserving laparoscopic resection of pancreatic head and duodenal papilla tumors [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 190-196.
[3]	YU Lan, ZHANG Yongyi, HUANG Lei, WAN Xin, JIANG Shengyao, TANG Sijing, ZHANG Jun, HU Weiguo. Risk factors of severe postoperative complications in elderly patients with pancreaticoduodenectomy [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 139-146.
[4]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 1-5.
[5]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 6-10.
[6]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 14-18.
[7]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 19-21.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 25-29.
[9]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 30-33.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 34-38.
[11]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 42-45.
[12]	YANG Chunxue, XU Haimin, DA Qian. Clinicopathological features of pancreatic intraductal oncocytic papillary neoplasm: a report of 5 cases [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 52-57.
[13]	XU Yu, ZHANG Junfeng, HUA Rong. Use of octreotide for prevention of pancreatic leak after pancreatoduodenectomy: study progress [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 83-86.
[14]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 84-86.
[15]	DING Fangmi, LIU Zhendong. Forkhead box D1 promotes invasion and metastasis of pancreatic cancer via extracellular signal-regulated kinase pathway [J]. Journal of Surgery Concepts & Practice, 2020, 25(06): 486-492.